15 December 2020

tranScrip is delighted to announce the appointment of Jo Cox as a Senior Partner. Jo Cox

Jo brings 19 years’ experience as a pharmaceutical physician across a number of different therapy areas and functions, including late phase clinical development, medical affairs, pharmacovigilance, and global regulatory submissions.

Jo’s clinical background is in obstetrics and gynaecology, primarily in the UK NHS, and spent 2 years in Australia. On joining Lilly UK, Jo worked in medical affairs on the women’s health portfolio, diabetes, urology and cardiovascular therapy areas, including product launches. 

Jo’s experience in global pharmacovigilance spans early and late phase oncology development. Jo was the safety lead on a breast cancer oncology programme as it progressed through clinical development to successful global regulatory submissions. In addition, Jo has recruited and managed medical teams of physicians, clinical research scientists and medical liaisons.

Prior to joining tranScrip, Jo was the clinical development medical lead on a large global phase 3 trial in early breast cancer.

Jo is a member of the Royal College of Obstetricians and Gynaecologists and an affiliate member of the Faculty of Pharmaceutical Medicine. Jo was previously a member of the NICE Guideline Review Panel for Women and Children’s Health, and the National Reproductive Health Research Network Board.

Flic Gabbay, tranScrip’s Managing Partner said, “We are delighted to have Jo join us, she brings a wealth of pharmaceutical medicine skills that are incredibly valuable to our organisation going forward, whether contributing to the programmes we already have or supporting even more new clients.”